| Pharmaceuticals Industry | Healthcare Sector | - CEO | XSHE Exchange | - ISIN |
| China Country | - Employees | - Last Dividend | 26 May 2026 Last Split | - IPO Date |
Shandong Boyuan Pharmaceutical Co., Ltd. stands out as a prominent figure in the pharmaceutical industry, focusing on the research, development, production, and sales of various pharmaceutical products. The company is committed to improving public health through innovation and maintaining high standards in pharmaceutical manufacturing. With a broad range of medications in its portfolio, Shandong Boyuan serves both the domestic and international markets, significantly contributing to the global healthcare landscape. Its dedication to excellence and ongoing improvement underlines its pivotal role in increasing the accessibility of vital medicines and promoting sustainable health solutions.
Shandong Boyuan Pharmaceutical Co., Ltd. offers a wide array of medications, covering various therapeutic areas to meet the diverse needs of the healthcare sector. These include: